SRNE
Sorrento Therapeutics Inc
$0.31
Earnings Summary
Revenue | $17.4Mn |
Net Profits | $-89.58Mn |
Net Profit Margins | -514.8% |
Highlights
Sorrento Therapeutics Inc’s revenue jumped 44.25% since last year same period to $17.4Mn in the Q3 2022. On a quarterly growth basis, Sorrento Therapeutics Inc has generated 51.82% jump in its revenue since last 3-months.
Sorrento Therapeutics Inc’s net profit jumped 25.23% since last year same period to $-89.58Mn in the Q3 2022. On a quarterly growth basis, Sorrento Therapeutics Inc has generated 59.05% jump in its net profits since last 3-months.
Sorrento Therapeutics Inc’s net profit margin jumped 48.17% since last year same period to -514.8% in the Q3 2022. On a quarterly growth basis, Sorrento Therapeutics Inc has generated 73.03% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Sorrento Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.25 |
EPS Estimate Current Year | -0.25 |
Highlights
Sorrento Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.25 - a 2% jump from last quarter’s estimates.
Sorrento Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.25.
Key Ratios
Key ratios of the Sorrento Therapeutics Inc post its Q4 2022 earnings
Earning Per Share (EPS) | 0 |
Highlights
Sorrento Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q4 2022. This indicates that the Sorrento Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2022-08-15 | -0.25 | -0.54 | -116% |
2023-03-09 | -0.25 | 0 | 100% |
2022-05-05 | -0.17 | -0.12 | 29.41% |
2022-11-08 | -0.25 | -0.2 | 20% |
₹0 US Stocks a/c Opening Fee